Clinical Trials Logo
  1. Home
  2. CDI
  3. NCT05508607

Precision Antimicrobial STewardship for Clostridioides DIfficile Prevention — PASTCDI  

CDI Clinical Trial

Official title:
Precision Antimicrobial STewardship for Clostridioides DIfficile Prevention

Clinical Trial Summary

To decrease CDI incidence by implementing an electronic health record-integrated CDI-risk classification tool for Clostridioides difficile infection (CDI) to focus a bundle of antimicrobial stewardship (AMS) CDI prevention recommendations on high-risk patients.

Clinical Trial Description

This study aims to use a pre/post implementation design to evaluate the use of a novel risk classification tool to improve existing methods of identifying patients eligible for routine antimicrobial stewardship (AMS) care processes targeting reduction of Clostridioides difficile infection (CDI). Antimicrobial stewardship is an established, evidence-based quality improvement program that is required by The Joint Commission and a condition of participation by the Centers for Medicare and Medicaid. AMS processes of care are evidence based, supported by published research demonstrating outcomes benefits, are recommended by national guidelines and are not investigational. Treatment decisions remain at the discretion of clinicians and patients ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05508607
Study type Observational
Source Intermountain Health Care, Inc.
Contact
Status Completed
Phase
Start date May 1, 2021
Completion date June 30, 2022
View Details
See also
  Status Clinical Trial Phase
Withdrawn NCT04241744 - Prospective Trial of Oral Vancomycin Therapy vs. Placebo for Prevention of CDI Phase 4
Completed NCT03462459 - Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection Phase 2
Completed NCT03497806 - Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection Phase 2
Completed NCT03621657 - The GRAFT Study: Gut RecolonizAtion by Fecal Transplantation Phase 2
Recruiting NCT04100603 - A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Clostridoides Difficile Infection
Completed NCT03788434 - Phase 2 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection Phase 2
Not yet recruiting NCT06237452 - VE303 for Prevention of Recurrent Clostridioides Difficile Infection Phase 3